单次跑出千万级GMV 大健康为什么离不开溯源？

This article shares the current development and value of traceability marketing in the big health industry, helping general consumers better select big health products and master reference standards to judge product quality.

1. After a decade of development, the core function of product traceability has shifted from early celebrity influencer-driven traffic acquisition to showcasing products’ actual origins, production processes, and process qualifications to consumers. It turns abstract quality promises into concrete purchasing references, addressing the pain point of information opacity in big health products.

2. Today, mature standardized traceability systems are mostly deployed in private channel ecosystems. Private domain traceability provides consumers with deeper product information, meeting core demands of big health consumers for safety, efficacy and suitability. Big health products with public traceability enjoy far higher consumer trust than those without, so consumers can prioritize these products when purchasing to reduce the risk of low-quality purchases.

This article summarizes on-the-ground implementation experience, growth opportunities and value logic of traceability marketing for big health brands, with a core conclusion that traceability will become a standard component of future brand marketing and is worth investment.

1. Consumer trends have shifted, with shoppers’ focus moving from influencers to products themselves. The core demand of big health consumers is safety and efficacy, and traceability perfectly solves trust pain points and improves information transparency, helping brands build a differentiated trust position in a homogenized market.

2. For marketing implementation, strong product capability is the core prerequisite for successful traceability collaboration with influencers. After securing partnerships, brands should arrange logistics coordination, product portfolio optimization, content refinement and scenario setup in advance. Brands with sufficient resources can build an in-house AI content team to maintain differentiated content competitiveness.

3. Traceability is not just a short-term sales driver: it also generates long-term reusable brand equity that drives repeat purchases. It also enables brands to restructure their online-offline business closed loop, converting one-time traffic into long-term served users.

This article sorts out practical implementation methods, growth opportunities and risk warnings of traceability models for big health sellers, which can be used directly as an implementation reference.

1. In terms of opportunities, the industry expects that private domain traceability will remain a huge growth opportunity for emerging sellers through at least 2026. Private domain traceability has three core competitive barriers: in-depth product selection, authentic transactions, and short conversion paths. Data shows that return rates for the same product category are over 10% lower in private domains than in public domains. AOV for top traceability special events can exceed ¥3,000, with a maximum recorded AOV of ¥40,000, and conversion performance far outperforms generic public domain traffic.

2. Risk warning: Offline traceability is an asset-heavy project, and brands bear full costs for the implementation team’s travel, accommodation, pre-shooting and other upfront expenses. Brands should clarify cost responsibilities and expenditure boundaries in advance to avoid unbalanced input-output ratios.

3. Practical guidance: To achieve predictable growth, sellers need to fully map out product, scenario, personnel, content, profit and fulfillment dimensions in advance. Sellers with sufficient resources can build a dedicated traceability implementation team to offset on-site uncertainty and ensure stable delivery outcomes.

This article outlines directions and practical insights for big health manufacturers to drive growth and connect with e-commerce through traceability models.

1. In terms of product development and design: today’s big health consumers increasingly value product transparency and safety. By opening full production process traceability, manufacturers can effectively eliminate consumer purchase concerns, build differentiated competitive advantages in a highly homogenized market, and align with current market demand.

2. In terms of business opportunities: traceability has developed into a implementable, replicable standardized system. Opening factory traceability allows manufacturers to meet collaboration needs from influencers, channels and private domain brands to gain more exposure and orders. Private domain traceability still has large room for growth, so manufacturers can proactively pursue relevant collaborations.

3. Insights for digital and e-commerce transformation: Manufacturers can build in-house content teams during traceability implementation to produce exclusive content. Content created through traceability can be reused long-term as brand equity, helping manufacturers extend from pure production to branded operations, and improve their own pricing power and risk resilience.

This article sorts out development trends of the big health traceability track, and summarizes customer pain points and corresponding solutions across different scenarios, for reference by relevant service providers in the big health industry.

1. Industry development trend: After 10 years of development, traceability marketing has shifted its core function from traffic-driven sales to building brand trust, and its implementation scenarios have shifted from generic public domain traffic to private domain proximity conversion. A replicable standardized operating process has now taken shape, and traceability will become a standard marketing tool for big health brands, with market demand continuing to grow.

2. Core customer pain points: Big health brands are extremely dependent on user trust, and traditional marketing cannot solve consumer trust problems. Cross-border brands face additional implementation difficulties including geographical barriers, cultural differences, and underdeveloped overseas supply chain support. For channels, offline traceability suffers from high levels of uncontrollable factors, unclear responsibility allocation and unstable delivery.

3. Solution directions: Service providers can help brands build standardized end-to-end traceability processes, absorb all complex full-link links in advance, plan materials and coordinate communication ahead of time for cross-border traceability to resolve implementation difficulties, and help brands accumulate reusable content assets to amplify the long-term value of traceability.

This article sorts out implementation logic, merchant demands and operation management experience for traceability business for platforms targeting the big health track, as a reference.

1. Core merchant demands: Traceability has now become an important path for big health merchants to acquire incremental growth. Merchants need platforms to provide clear standardized traceability processes, explicit responsibility allocation, and stable delivery guarantees to help them achieve predictable growth outcomes.

2. Proven mature practices for platform operation and management: Build a clearly structured dedicated traceability team, split responsibilities between overall coordination and on-site management, arrange dual streamers to balance rhythm and broaden audience reach, staff all specialized roles, and guarantee delivery outcomes through fixed division of labor and standardized processes. For profitability, set commission ranges based on product cost to build a reasonable revenue structure, conduct full-cycle expectation management with merchants in advance to align expectations on input and returns, and ensure mutually beneficial cooperation.

3. Risk mitigation: Offline traceability is an asset-heavy project, so platforms should clarify cost responsibilities and expenditure boundaries with brands in advance to avoid disputes over unbalanced input-output ratios. Platforms should prioritize collaboration with brands that have strong product capability and mature business understanding to improve project success rates.

This article sorts out the development and evolution of traceability marketing in the big health industry, and summarizes new industry trends, problems and business models, for reference by industry researchers.

1. New industry trends: After a decade of development, traceability marketing has gradually evolved its function: from early quality endorsement, to traffic-driven sales in the live-stream e-commerce era, and now to private domain trust building in the post-growth存量 era. A implementable, replicable standardized operating system has now taken shape, becoming a core path for big health brands to break through growth ceilings. The industry generally expects traceability to become a standard component of future brand marketing.

2. New emerging industry problems: Traditional public domain traceability that relies on traffic harvesting has already hit a growth ceiling. Cross-border traceability faces multiple barriers related to geography, culture and supply chains, while offline traceability suffers from high costs, numerous uncontrollable factors and unclear responsibility allocation, all of which require further exploration of solutions.

3. New business model: The emerging new model of private domain traceability has built three core competitive barriers: in-depth product selection, authentic transactions, and short conversion paths. Traceability has also transformed from a one-time promotion to a sustainable content production system and accumulable brand equity, restructuring the people-product-scene relationship in the big health industry and opening up new possibilities for industry growth.